The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Strategies to increase accrual of underrepresented populations in Alliance NCTN trials.
 
Electra D. Paskett
Stock and Other Ownership Interests - Meridian Bioscience Inc; Meridian Bioscience Inc (I); Pfizer; Pfizer (I)
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Genentech (Inst); Guardant Health (Inst); Merck (Inst); Pfizer (Inst)
 
Niveditha Subbiah
No Relationships to Disclose
 
Marie Wood
Consulting or Advisory Role - AstraZeneca (Inst); HERON (Inst)
Speakers' Bureau - MJH Life Sciences
 
Craig Steffens
No Relationships to Disclose
 
Judith Salmon Kaur
No Relationships to Disclose
 
Lucile L. Adams-Campbell
No Relationships to Disclose
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories
Honoraria - CStone Pharmaceuticals
Consulting or Advisory Role - Bayer; BioAtla; Blueprint Medicines; Daiichi; deciphera; Immunicum; Kayothera; Lilly; MORE Health; Research to Practice; UpToDate
Research Funding - BioAtla; Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); IDRx (Inst); Merck (Inst); SpringWorks Therapeutics (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Expert Testimony - Bayer
Other Relationship - Research to Practice; WCG